Ningbo David Medical Device Co., Ltd. (SHE:300314)

United States Steel Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	482.76	516.93	606.83	496.58	469.87	455.63
Other Revenue	10.1	10.1	11.47	9.46	4.26	3.9
Revenue	492.86	527.03	618.3	506.04	474.13	459.53
Revenue Growth (YoY)	-19.96%	-14.76%	22.18%	6.73%	3.18%	28.95%
Cost of Revenue	221	233.47	263.61	210.28	185.25	189.66
Gross Profit	271.86	293.55	354.68	295.76	288.88	269.87
Selling, General & Admin	172.22	172.44	172.15	155.19	166.5	123.36
Research & Development	59.07	55.46	48.06	45.87	49.69	40.22
Other Operating Expenses	5.91	5.03	6.72	7.98	6.81	6.96
Operating Expenses	237.63	233.16	227.43	210.26	223.27	170.9
Operating Income	34.24	60.39	127.25	85.5	65.61	98.97
Interest Expense	-0.78	-0.47	-0.6	-0.35	-0.03	-
Interest & Investment Income	12.73	10.71	25.87	5.39	18.9	49.4
Currency Exchange Gain (Loss)	0.83	0.83	6.33	17.05	-2.86	-3.3
Other Non Operating Income (Expenses)	-0.31	-0.46	-0.3	-0.27	-0.23	-0.26
EBT Excluding Unusual Items	46.71	71.01	158.55	107.31	81.38	144.81
Impairment of Goodwill	-0.52	-0.52	-1.53	-	-	-
Gain (Loss) on Sale of Investments	-7.51	-10.06	0.26	-4.88	0.69	-
Gain (Loss) on Sale of Assets	0	-0.01	-0.23	0.02	0.12	0
Asset Writedown	-0.01	-0.01	-0.08	-0.02	-0.04	-0.03
Other Unusual Items	6.15	2.98	9.24	9.49	5.05	1.86
Pretax Income	44.82	63.38	166.22	111.92	87.19	146.65
Income Tax Expense	3.09	6.12	18.61	14.56	6.99	10.46
Net Income	41.72	57.26	147.61	97.36	80.21	136.19
Net Income to Common	41.72	57.26	147.61	97.36	80.21	136.19
Net Income Growth	-69.25%	-61.21%	51.62%	21.39%	-41.11%	119.46%
Shares Outstanding (Basic)	286	286	289	286	286	290
Shares Outstanding (Diluted)	286	286	289	286	286	290
Shares Change (YoY)	-1.10%	-1.08%	1.08%	-0.04%	-1.14%	2.73%
EPS (Basic)	0.15	0.20	0.51	0.34	0.28	0.47
EPS (Diluted)	0.15	0.20	0.51	0.34	0.28	0.47
EPS Growth	-68.91%	-60.78%	50.00%	21.43%	-40.43%	113.64%
Free Cash Flow	-54.85	-45.82	94.81	61.79	44.95	113.53
Free Cash Flow Per Share	-0.19	-0.16	0.33	0.22	0.16	0.39
Dividend Per Share	0.087	0.087	0.180	0.150	0.100	0.150
Dividend Growth	-51.67%	-51.67%	20.00%	50.00%	-33.33%	275.00%
Gross Margin	55.16%	55.70%	57.36%	58.45%	60.93%	58.73%
Operating Margin	6.95%	11.46%	20.58%	16.89%	13.84%	21.54%
Profit Margin	8.47%	10.87%	23.87%	19.24%	16.92%	29.64%
Free Cash Flow Margin	-11.13%	-8.70%	15.33%	12.21%	9.48%	24.70%
EBITDA	55.89	83.18	154.57	108.93	89.76	120.46
EBITDA Margin	11.34%	15.78%	25.00%	21.53%	18.93%	26.21%
D&A For EBITDA	21.66	22.79	27.32	23.43	24.15	21.49
EBIT	34.24	60.39	127.25	85.5	65.61	98.97
EBIT Margin	6.95%	11.46%	20.58%	16.89%	13.84%	21.54%
Effective Tax Rate	6.90%	9.65%	11.20%	13.01%	8.01%	7.13%
Revenue as Reported	492.86	527.03	618.3	506.04	474.13	459.53
Advertising Expenses	-	3.22	4.51	3.32	4.06	1.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.